Business Context and Reporting Period
This Form 8-K reports on the results of the 2017 Annual Meeting of Stockholders held by MediciNova, Inc. on June 8, 2017. The record date for the meeting was April 13, 2017, with 34,540,453 shares of common stock issued and outstanding. A quorum was established with 25,449,727 shares present.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Three proposals were submitted to stockholders, all of which were approved:
- Election of Director: Jeff Himawan was elected as a Class I Director to serve until the 2020 Annual Meeting. He received 23,199,272 votes "For" and 992,666 votes "Withheld."
- Ratification of Auditors: Stockholders ratified the selection of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2017. The proposal received 24,662,983 votes "For" and 355,473 votes "Against."
- Equity Plan Amendment: Stockholders approved an amendment to the 2013 Equity Incentive Plan to increase the number of shares issuable under the Plan by 1,200,000 shares. The proposal received 22,543,865 votes "For" and 1,113,591 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the effective date of the 1,200,000 share increase to the 2013 Equity Incentive Plan.
- Confirm the term end date for the newly elected director, Jeff Himawan (2020 Annual Meeting).
- Review the definitive proxy statement filed on April 27, 2017, for detailed background on the proposals.